ERA - Leading European Nephrology

My ERA Join ERA

Home | Video pages | Webcast | Calcification propensity: from biomarker to treatment target?

Calcification propensity: from biomarker to treatment target?

Share

https://www.youtube.com/watch?v=LrR-sHWYnuQ copy

Other e-seminars from CKD-MBD & EuReCa-M

A patient after kidney transplantation with fractures – bone anabolic therapy in CKD

Thyroid Hormone in CKD patients with diabetes: what is known, what is new

Targeting bone in CKD without biopsy – novel non-invasive treatment targets

Long-term cardiovascular complications following AKI

A patient with CKD5D receiving haemodialysis treated with denosumab

Calcimimetics vs parathyroidectomy in CKD and transplantation: the never-ending story

What does the Cardiovascular-Kidney-Metabolic (CKM) Syndrome mean for nephrologists?

AKI to CKD transition

A 70-year-old man with CKD G4, osteoporosis and low bone turnover

Endocrine functions of the bone and their potential contributions to systemic CKD complications

SGLT2 inhibitors and haemoglobin increase: a possible explanation of the cardiovascular benefits?

A patient with CKD and an atypical bone fracture after long-term use of bisphosphonates